Related Experiment Video
Updated: Jun 5, 2026
16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
[Objectives of hemodynamic resuscitation]
J Mesquida1, X Borrat, J A Lorente
1Área de Críticos, Hospital de Sabadell, Institut Universitari Parc Taulí, Sabadell, Barcelona, España. jmesquida@tauli.cat
Medicina Intensiva
|January 7, 2011
Summary
Cardiovascular shock causes tissue hypoxia and lactic acidosis. Optimizing perfusion pressure and oxygen delivery, monitored by lactate and ScvO2/SvO2, is key for effective resuscitation and improved outcomes.
Area of Science:
- Critical Care Medicine
- Cardiovascular Physiology
- Metabolic Resuscitation
Context:
- Cardiovascular failure leads to inadequate tissue perfusion, disrupting oxygen balance.
- Cellular hypoxia shifts metabolism to anaerobic pathways, increasing lactate and causing metabolic acidosis.
- The severity of hyperlactatemia and acidosis correlates with organ failure and patient prognosis.
Purpose:
- To highlight the importance of optimizing perfusion pressure and oxygen delivery in shock resuscitation.
- To emphasize the role of monitoring lactate and venous oxygen saturations (ScvO2/SvO2) in assessing tissue hypoxia.
- To discuss emerging technologies for evaluating microcirculation and their potential role in resuscitation.
Summary:
- Effective resuscitation hinges on achieving adequate perfusion pressure and optimizing oxygen delivery to restore aerobic metabolism.
- Monitoring lactate levels and central/mixed venous oxygen saturation (ScvO2/SvO2) helps guide resuscitation efforts.
- While new technologies offer insights into microcirculation, current resuscitation remains focused on hemodynamic parameters and oxygen delivery.
Impact:
- Guides clinicians in prioritizing hemodynamic resuscitation strategies for shock patients.
- Informs the use of physiological monitoring to assess resuscitation effectiveness and patient outcomes.
- Provides a foundation for future research into advanced monitoring techniques during shock resuscitation.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:21Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...